35
Views
42
CrossRef citations to date
0
Altmetric
Original Article

Frequent Occurrence of Non-Specific Gliadin Antibodies in Chronic Liver Disease Endomysial but Not Gliadin Antibodies Predict Coeliac Disease in Patients with Chronic Liver Disease

, &
Pages 1162-1167 | Received 24 Feb 1997, Accepted 16 Jul 1997, Published online: 08 Jul 2009
 

Abstract

Background: The frequency of gliadin antibody (GA) positivity has been found to be increased among patients with chronic liver disease, as has that of coeliac disease (CD). CD has also been found to be increased among patients with primary biliary cirrhosis (PBC) or primary sclerosing cholangitis (PSC). Methods: To investigate these relationships further, a micro-enzyme-linked immunosorbent assay and immunofluorescence tests for GAs and endomysial antibodies (EMAs) were performed in large subgroups of patients representing various chronic liver diseases and in healthy blood donors. Results: As compared with blood donors (among whom it was 5%) the frequency of IgA GA positivity was higher in all patient subgroups: alcoholic liver disease, 20% (22 of 110, P< 0.001); PBC, 16% (16 of 101, P< 0.001); PSC, 24% (19 of 80, P< 0.001); chronic hepatitis, 19% (13 of 70, P< 0.001); and hepatitis C virus infection, 11% (11 of 104, P< 0.01). Two patients with autoimmune chronic hepatitis were EMA-positive, and in both cases the presence of CD was verified by small-bowel biopsy. Conclusions: IgA GA positivity generally occurs at increased frequency among patients with chronic liver disease and may represent nonspecific immune activation. In liver disease GA testing is not useful in screening for CD, whereas the EMA test seems to be highly specific. CD is more prevalent than expected among patients with autoimmune chronic hepatitis but not among those with PBC or PSC.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.